11health Raises £1.25 Million from Leading City Figures

11health, a British medical technology business, has completed a new round of funding, raising a total of £775,000 from six angel investors, on top of the initial funding round of £500,000. This brings the total funding to over £1.25 million. This round of funding enables the business to extend the management team and more effectively pursue an aggressive sales and marketing strategy in the UK and the US. It will also further establish the award-winning Ostom-i Alert as the leading medical device for bowel disease patients and develop other connected device products across the healthcare marketplace.

To support the growth strategy, 11health has appointed James Barbour-Smith as Executive Chairman. He will be responsible for the continued financial growth and strategic direction of the firm. James brings to the role over 20 years of global experience in developing and building businesses through his role as Head of Portfolio at Gresham Private Equity.

As part of its US growth strategy, 11health has hired Matthew Wilder, who joins the US team as Vice President of Sales. Matthew will be responsible for implementing sales and driving growth across America. Matthew has extensive experience in medical sales and played for the American Football Team, The Miami Dolphins. The firm is in advanced discussions and trials with a number of well-respected hospitals in the U.S. including: Stanford University, Massachusetts General and Cedars Sinai (LA).

Michael Seres, Founder, 11health said: "We are pleased to welcome James and Matthew to 11health and look forward to the unique contribution that they will bring to the business. As a connected device company, focused initially on stoma care, our ambition is to become the leading connected device across all medical bags and pouches. These important new appointments, along with this funding will reinforce our growing presence in the U.S. and British markets, and help bring our global vision to reality."

He continued: "We are moving forward at a tremendous pace, and this additional funding will really help us accelerate our product development especially into new markets and build out our sales teams in the UK and in the U.S."

Michael Seres, a long-term patient turned innovator, founded 11health in 2013 with Adam Bloom when he created the Ostom-i Alert device from his hospital bed, after being the 11th person in the UK to undergo a small bowel transplant in 2011.

About 11health
11health is a fast-growing British medical technology business, co-founded in 2013 by Michael Seres and Adam Bloom. Michael was diagnosed with the incurable bowel condition Crohn’s Disease aged 12. After over 20 operations and intestinal failure he became the 11th person to undergo a small bowel transplant in the UK at The Churchill Hospital, Oxford, England. His own experience as an ostomy patient led him to designing the initial Ostom-i prototype whilst recovering from transplant.

A published author and professional speaker Michael was a Stanford Medicine X e-patient scholar (2011) and develops patient engagement strategies for hospitals, primary care trusts and patient groups. He has a background in consumer product licensing and merchandising having worked with major brands such as FIFA, UEFA, The X Factor and The Apprentice. He is the patient lead for the main UK health twitterchat #NHSSM & digital strategy advisor to The Oxford Transplant Foundation where he helped implement the first skype clinics.

Most Popular Now

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI Model Converts Hospital Records into …

UCLA researchers have developed an AI system that turns fragmented electronic health records (EHR) normally in tables into readable narratives, allowing artificial intelligence to make sense of complex patient histories...

AI Sharpens Pathologists' Interpret…

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately...

AI Tool Detects Surgical Site Infections…

A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with high accuracy from patient-submitted postoperative wound photos, potentially transforming...

Forging a Novel Therapeutic Path for Pat…

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...